CORT · Corcept Therapeutics Inc
United States · RS rating 48 · As of 2026-11-03
| Price | 81.93 USD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 10 / 25 / 61 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 30 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.0% |
| Sales growth Q/Q | -2.7% |
| Distance from 52-week high | +33.7% |
| Market cap (USD) | $4.8B |